Rational Neonatal anoxia-ischemia (AI) particularly affects the central nervous system. Despite the many treatments that have been tested, none of them has proven to be completely successful. Palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) are acylethanolamides that do not bind to CB1 or CB2 receptors and thus they do not present cannabinoid activity. These molecules are agonist compounds of peroxisome proliferator-activator receptor alpha (PPARα), which modulates the expression of different genes that are related to glucose and lipid metabolism, inflammation, differentiation and proliferation. Objective In the present study, we analyzed the effects that the administration of PEA or OEA, after a neonatal AI event, has over different areas of the hippocampus. Methods To this end, 7-day-old rats were subjected to AI and then treated with vehicle, OEA (2 or 10 mg/kg) or PEA (2 or 10 mg/kg). At 30 days of age, animals were subjected to behavioral tests followed by immunohistochemical studies. Results Results showed that neonatal AI was associated with decreased locomotion, as well as recognition and spatial memory impairments. Furthermore, these deficits were accompanied with enhanced neuroinflammation and astrogliosis, as well as a decreased PPARα expression. PEA treatment was able to prevent neuroinflammation, reduce astrogliosis and preserve cognitive functions. Conclusions These results indicate that the acylethanolamide PEA may play an important role in the mechanisms underlying neonatal AI, and it could be a good candidate for further studies regarding neonatal AI treatments.
Introduction
Neonatal hypoxia ischemia (HI) is an event that is usually triggered during birth. Either fetus lung malfunction or modifications in the placental gas exchange can lead to low levels of oxygen (hypoxia or anoxia) or a diminished blood flow (ischemia) in the fetus Carrera 2006) . Neonatal HI particularly affects the central nervous system (CNS) (Kumar et al. 2007) , which is highly susceptible to oxidative stress, in part due to the elevated concentration of fatty acids present in this tissue (Halliwell, 1992) . So far, hypothermia has been the only treatment that was able to consistently prevent the neurological damage and sequels associated to neonatal HI (Mishima et al. 2004; Sebetseba et al. 2017 ). Neonatal HI is associated to learning and memory impairments Galeano et al. 2011 Galeano et al. , 2015 Takada et al. 2016 ). Mainly, it has shown to cause several cellular and molecular modifications in the hippocampus, including astrogliosis and focal swelling, among others Saraceno et al. 2010 Saraceno et al. , 2012 .
The endogenous cannabinoid system (ECS) includes different enzymes responsible for endocannabinoid synthesis, transport and degradation, as well as endocannabinoids and endocannabinoid receptors (Ueda et al. 2013 ). The ECS is important for its regulation over different neurological and physiological processes, that include neural development, synaptic plasticity, reward processing, learning processes, neurogenesis and embryonic cell fate in the developing brain, through the activation of cannabinoid receptors 1 (CB1) and 2 (CB2) (Ahmad and Laviolette 2017; Alonso-Alconada et al. 2011; Blanco-Calvo et al. 2014; Serrano et al. 2012; Schoch et al. 2018; Ueda et al. 2013; Zhou et al. 2017) .
Endocannabinoids are produced from membrane phospholipids depending on cell demand, and they are soon degraded by the corresponding enzyme. These compounds are divided into two groups of fatty acid derivatives that present specific structures: acylethanolamides (AEs) and monoacylglycerols (MAGs) (Hansen and Diep 2009; Serrano et al. 2012; Ueda et al. 2013) . To date, the further characterized endocannabinoids are arachidonoyethanolamide (AEA, an AE also known as anandamide) and 2-arachidonoyglycerol (2AG, a MAG). AEs are synthesized from glycerophospholipids and degraded by the fatty acid amide hydrolase (FAAH) (Okamoto et al. 2009; Pasquarelli et al. 2015; Ueda et al. 2013) . Other ethanolamine and palmitic acid amides such as palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) are AEs that share both biosynthetic and degradative pathways with AEA. However, these amides do not bind to CB1 and CB2 and thus they do not present cannabinoid activity (Fu et al. 2003; Scuderi et al. 2011) . These molecules have been described as agonist of peroxisome proliferator-activator receptor alpha (PPARα), which is expressed in microvascular, neuronal and glial tissues, and plays a key role in glucose and lipid metabolism, inflammation, differentiation and proliferation (Cristiano et al. 2005; Xu et al. 2006) . Furthermore, this receptor has been shown to play a key role as a neuroprotectant in different disorders (Bhateja et al. 2012; Bordet et al. 2006; Moran et al. 2014) .
In previous studies, it has been shown that OEA and PEA present neuroprotective effects in cerebral ischemia (Ahmad et al. 2012; Naccarato et al. 2010; Yang et al. 2015; Zhou et al. 2012) . Moreover, former studies from our group have shown diminished PPARα levels in hippocampus and striatum of animals that had been exposed to perinatal asphyxia Holubiec et al. 2017) . In the present study, we aimed to analyze the effect that the administration of both PEA and OEA, after a neonatal anoxic-ischemic (AI) event, has over different areas of the hippocampus. To this purpose, the expression of different markers (Iba-1, GFAP and PPARα) was studied and an array of behavioral tests was performed.
Materials and methods

Experimental subjects
Experiments in this study were performed in accordance with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) and following the standards disposed by the European Directive 2010/63/EU and the Spanish Royal Decree 53/2013 on the protection of animals used for research and other scientific purposes. All experiments (including the used of experimental animals) were approved by the ethic committee BComité de Ética e Investigación Biosanitaria^of the IBIMA and University of Málaga. Female Sprague Dawley pregnant rats were kept in a vivarium under standard controlled conditions (temperature: 21 ± 2°C; humidity: 65 ± 5%; dark/light cycle: 12 h/12 h), and were supplied with ad libitum access to food (Purina chow) and tap water. Twentyone days after the delivery date, pups were removed from their dams and housed in cages of four animals each under the same standard conditions as mentioned for the pregnant animals. Only male pups were selected to perform the present study since clinical and animal evidence show that neonatal HI has a more robust effect on males (Smith et al. 2014 ).
Common carotid artery ligation and anoxia procedures
The neonatal anoxia-ischemia model that was used in the present study has been already validated (López-Aguilera et al. 2012; Romero et al. 2015 Romero et al. , 2017 . Dams were monitored daily in order to determine the exact date of birth of the pups. When the animals were 7 days old (P7), males were selected to be subjected to carotid artery ligation. Pups were anesthetized using a mixture of 40 mg/kg ketamine and 4 mg/kg xylazine in order to also produce analgesia. When the animals were ready, they were placed in a heated pad to prevent their body temperature from dropping below 37°C. The area to be operated on was properly disinfected and an incision was made in order to reach the right common carotid artery. When the artery was free of surrounding tissue, it was properly ligated using a 6-0 surgical silk thread. After a 2-h recovery period, the pups were subjected to a 100% nitrogen environment at 37°C for 3 min to induce anoxia (AI group n = 41). The control group was also subjected to the surgical procedure; however, the artery was exposed but not ligated. These animals were not exposed to the anoxia treatment either (Sham group = 42). The mortality rate was of 5% and it was only attributed to the surgical procedure and not to the anoxia. This mortality rate is in the lower range found in HI models (Schwartz et al. 1992; Vannucci and Vannucci, 2005) .
PEA and OEA treatments
An hour after the artery ligation and nitrogen exposure (or sham procedures) were finished pups were injected intraperitoneally (i.p.) with a DMSO solution [vehicle, n = 10 sham pups (Sham-Veh) and 9 AI pups (AI-Veh)], 2 mg/kg of OEA [n = 7 sham pups (Sham-O2) and n = 7 AI pups (AI-O2)], 10 mg/kg of OEA [n = 9 sham pups (Sham-O10) and n = 9 AI pups (AI-O10)], 2 mg/kg of PEA [n = 7 sham pups (Sham-P2) and n = 7 AI pups (AI-P2)], and 10 mg/kg of PEA [n = 9 sham pups (Sham-P10) and n = 9 AI pups (AI-P10)]. Each male pup was assigned to the experimental groups in a randomly way but with one condition (therefore, pseudo-randomly): that each experimental group was composed of pups from at least three different dams, in order to avoid the effect known as Blitter effect.T wenty-three days after the carotid ligation treatment (or sham procedures), animals were subjected to a battery of behavioral tests and then euthanized and brains collected for immunohistochemistry analysis.
Behavioral assessment
When rats were 30 days old, 7-10 animals from each of the groups were subjected to a number of behavioral tests (Elevated Plus Maze, Open Field, Object Recognition, Morris Water Maze and Passive Avoidance tests). Every animal was subjected to a period of handling prior the beginning of the behavioral assessment (5 min per day during three consecutive days). The whole set of tests was carried out during the 12 h of light and soft background noise was provided throughout the whole process. Training sessions were recorded (JVC Everio GZHD620 camcorder) and analyzed using a computerized video-tracking system (ANY-maze, Stoelting Co., Wood Dale, IL) or with the ethological software J WatcherV1.0.
Elevated plus maze test
The elevated plus maze (EPM) test was carried out in a plus shaped device consisting of a central platform (11 × 11 cm) and four equally long arms: two open (50 × 11 × 0.25 cm) arms and two arms surrounded by walls (50 × 11 × 40 cm) . The device was set 100 cm above the floor. The apparatus was evenly illuminated with an intensity measured in open arms of 85-90 lx. For each trial, the animal was placed in the middle of the device facing one of the open arms. Animals were left to explore the apparatus for 5 min. An entry to an arm was counted when the rat set all four paws into one arm. Total distance covered, number of times the animal 
Open field test
For the open field (OF) test, an evenly illuminated black arena was utilized (60 × 60 cm and 40 cm high) . In order to delimit the central and most illuminated area (70 lx) of the arena, an imaginary square of 30 × 30 cm was drawn over the image of the apparatus during the data analysis. Animals were carefully set in the apparatus and left to explore it for 10 min. An animal was considered to be in the central area when its four paws were on the delimited 30 × 30 cm square. Distance covered, number of rears, number of entries and time spent into the central area were recorded in two time bins of 5 min each.
Novel object recognition test
The novel object recognition test (NORT) was carried out 24 h following the OF, using the same arena. NORT is a widely employed and validated test to assess recognition memory (Ennaceur 2010; Ennaceur and Delacour 1988) . During the test, animals were set in the arena where two identical objects were placed. Rats were allowed to explore the apparatus and the objects for 5 min (sample trial). This trail was followed by a period (1 h) in which animals were returned to their cages. Rats were then returned once more to the arena and were presented with one familiar object and a novel one. Animals were given 3 min to explore the objects and then returned to their cages (retention trial). The apparatus was evenly illuminated at approximately 70 lx and the device and the objects were thoroughly clean between animals. All possible location or object combinations were employed to prevent bias due to a preference for a particular object or specific location. Animals were considered to be exploring an object when their snout was directed towards it at a distance of 2 cm or less. Discrimination index (d1) and ratio (d2) scores were calculated using the following formulas: d1 = tn -.tf, and d2 = (tn -tf) / (tn -tf), where tn is the amount of time that rats expend exploring the novel object and tf is the amount of time rats explored the familiar object.
Morris water maze test
For the Morris water maze (MWM) a black steel tank (180 cm diameter; 60 cm deep) filled with water at 22 ± 1°C and a translucent circular platform were used (Galeano et al. 2011 . Different visual cues were located on the walls surrounding the maze and the whole setting was indirectly illuminated. The tank was divided by the operators in four equal quadrants and the platform was set in the middle of one of the quadrants. According to each quadrant, four starting positions were determined. Latency to platform, distance to platform and swim speed were registered during spatial learning training. In the probe trial, the platform was removed and the percentage of time spent in each quadrant and the numbers of crossings over a circular area (with a diameter larger than platform diameter) located on the previous platform position were recorded.
In the cued learning phase, the surrounding visual cues were covered with a black curtain and the platform was set 2 cm above water level with a flag attached to it. Eight cued learning trails were performed during 2 days (four each day). The location of the platform and the starting point were modified for each trial. If after 60 s the animal had not found the platform, it was gently guided to it and left there for 15 s. To assess spatial learning and reference memory, the black curtain was removed and the visual cues were available while the platform was set under water (2 cm below the water surface). The test consisted of four trials each day performed over the period of 6 days. The animal was released from one of the starting positions and it was left to explore the maze looking for the hidden escape platform (the platform remained in the same location for all the trails). If the animal was unable to find the platform after 60 s, it was guided to it and left there for 15 s. During each trial, the starting position was changed and the sequence used varied along the 6 days of the test. Reference memory was assessed 24 h after the last learning trail with a probe trial of 60 s. For this probe trial, the animal was released from a novel starting position and the platform was removed from the maze.
Passive avoidance
The passive avoidance test was used to assess associative memory (Deacon et al. 2002) . The device consisted of a box (60 cm × 60 cm × 40 cm) divided in two. The resulting compartments were both 30 cm long and separated by a door that opened sliding into the floor. One of the compartments was made of white plastic and well illuminated. The second compartment was dim and made of dark, electrifiable metal.
During the acquisition phase, the rat was placed in the light compartment and it was allowed to freely explore de devise. The moment the animal crossed into the black compartment, it received a mild foot shock (1.2 mA, 2 s duration) and it was promptly removed from the device. One hour later, the retention trial took place and the rat was again placed in the white compartment and was left to freely explore the entire apparatus during a maximum of 10 min (no foot shock was delivered once it entered the dark compartment). The ratio between the latency of the rat to move into the dark compartment in the retention trial (T2) and in the training sessions (T1) was taken as a measure of associative memory retention (T2/T1) (Deacon et al. 2002) .
Tissue processing
After the behavioral assessment was finished, 4-5 randomly chosen rats per group were administered with a mixture of 40 mg/kg ketamine and 4 mg/kg xylazine and subjected to an intracardiac perfusion. The thoraxic cavity was open and an 24G butterfly needle was carefully inserted in the left ventricle. We firstly apply saline solution (0.9% Sodium Chloride) with 1% (v/v) heparin at a rate of 9.99 ml/min in order to clean the tissues. When the right auricle was swollen, a small incision was made in order to open the system and let the blood and the solutions applied flow. After 5 min of Sodium Chloride, a cold 4% formaldehyde solution (freshly made from paraformaldehyde; Sigma-Aldrich, St. Louis, MO, USA) was applied for 20-30 min. When the tissue was properly fixated, the brain was carefully extracted and post fixed in 4% formaldehyde solution for 2 h at 4°C. Finally, 40-μm thick coronal sections were obtained from each brain and they were properly stored in a 0.002% (w/v) NaN 3 solution at 4°C.
Immunohistochemical procedures
The presence of markers related to neuroinflammation, astrogliosis and the expression of PPARα were assessed using immunohistochemistry. For this purpose sections from each group were placed in separate wells in a 24 well plate. Samples were washed 5 times for 10 min using 0.1 M phosphate buffer solution with 0.5% Tween 20 (PBS-T), at room temperature (RT) in order to properly eliminate the formaldehyde that was used as a fixative agent. To block the endogenous peroxidase, sections were incubated with 30% H 2 O 2 in PBS during 30 min at RT. Samples were then washed 5 times for 10 min with PBS-T and unspecific antigens were blocked incubating the sections in 4% BSA (Bovine Serum Albumin), diluted in PBS-T, for 1 h at RT. Afterwards samples were washed 5 times for 10 min with PBS-T and then incubated with the corresponding primary antibody [rabbit anti-Iba-1 (1:1000, Wako, Osaka, Japan; cat. no. 019-19741; mouse anti-GFAP (1:500, G3893, Sigma; rabbit anti-PPARα (1:100, P11120812, Fitzgerald)] over night at 4°C. The following day samples were washed 5 times for 10 min using PBS-T and subsequently incubated with horseradishperoxidase (HRP) biotinylated secondary antibody (donkey anti-rabbit IgG, 5356499, GE Healthcare; goat anti-mouse IgG, 125K6063, Sigma) for 2 h at RT. Once the 2 h had elapsed, samples were again washed 5 times for 10 min with PBS-T and incubated with ABC (Avidin-Biotin complex) solution (1:1000; ExtrAvidin peroxidase, Sigma, St Louis, MO, USA) for 1 h in darkness at RT. The ABC solution was washed 5 times for 10 min using PBS-T. Finally the signal was detected using 0.05% diaminobenzidine (DAB; Sigma) diluted in PBS containing 0.03% H 2 O 2 . Sections were then washed several times using running water, mounted on slides treated with poly-L-lysine solution (Sigma) and subjected to a process of dehydration (increasing ethanol concentration followed by xylene). Samples were covered with cover slips using Eukitt mounting medium (Kindler GmBH & Co., Freiburg, Germany). After they were dry, samples were observed using an Olympus BX41 Microscope coupled with an Olympus DP70 digital camera (Olympus, Germany) or an Olympus BX60 microscope coupled to Olympus DP71 digital camera (Olympus, USA). All the photographs were taken under the same conditions of light and brightness/contrast.
Immunohistochemical quantification
Four to seven coronal sections from Bregma levels −3.14 to −4.30 mm (dorsal hippocampus) (Paxinos and Watson 2007) , from each animal, were selected and employed for immunohistochemical analysis. Quantification was carried out using the BCell counter^plug in tool from Image J software (NIH, USA). Images were changed to binary code and the area of interest delimited. For Iba-1 and GFAP quantification, 0.08 mm 2 squares were set and distributed so that each area of the hippocampus studied (CA1, CA3 and DG) was properly represented, while 0.02 mm 2 squares were employed in the case of PPARα. The number of positive cells was manually determined in each square and averaged to determine the number of cells per mm 2 . Quantifications were made by experimenters blinded to treatments.
Statistics analysis
Behavioral and immunohistochemical data were analyzed by two-way ANOVA tests followed by Tukey's post hoc multiple comparison tests. We employed one-sample t tests to analyze the discrimination index (d1) and discrimination ratio (d2) in the NORT, and the percentage of time spent in the target quadrant during the probe trial in the MWM. We chose onesample t tests, rather than ANOVA models, since our intention was to know if each group of rats remembered or not the familiar object or the quadrant where the platform was, and not to compare the performances of groups between themselves. Since multiple t tests were carried out, p values were corrected by the Benjamini-Hochberg procedure (Benjamini and Hochberg, 1995) . Briefly, in this method original p values are first sorted and then ranked from the smallest one (1) to the largest one (N). Then, each original p value is multiplied by N and divided by its assigned rank to give the adjusted p values. Online calculators are available (see for instance: https://www. sdmproject.com/utilities/?show=FDR). A probability equal or less than 5% was accepted as statistically significant and always two-sided probabilities were reported. Data are expressed as mean ± SEM.
Results
Neonatal anoxia-ischemia reduces exploratory activity without modifying anxiety-like behaviors in the EPM and OF tests
Elevated plus maze test
When the distance covered was analyzed, a two-way ANOVA test revealed that the main factor Postnatal condition was significant (F (1, 73) = 40.7, p < 0.001), while neither the main factor Treatment nor the interaction Postnatal condition × Treatment were significant (F (4, 73) = 1.4, p = n.s.; F (4, 73) < 1, p = n.s.). Similarly, in the case of closed arms entries, the main factor Postnatal condition was significant (F (1, 73) = 16.2, p < 0.001), while neither the main factor Treatment nor the interaction Postnatal condition × Treatment were significant (F (4, 73) < 1, p = n.s.; F (4, 73) < 1, p = n.s.). These results indicate that rats that were subjected to anoxia-ischemia, regardless of the treatment received, covered a significantly lower distance and visited significantly fewer times the closed arms in comparison with sham groups (see Fig. 1a F (4, 73) < 1, p = n.s.; Postnatal condition x Treatment, F (4, 73) < 1, p = n.s.) (see Fig. 1c, d ).
Open field test
Two-way mixed ANOVA test revealed that the main factors Group and Time, and the interaction Group × Time were all significant (F (9, 146) = 4.4, p < 0.001; F (1, 146) = 132.4, p < 0.001; F (9, 146) = 3.2, p = 0.001, respectively), in the case of distance covered. Post hoc multiple comparison Tukey tests showed that rats subjected to anoxia-ischemia covered a significantly lower distance than sham groups during the first 5 min (see Fig. 2a ). All the groups significantly reduced their distance covered to the same levels during the second 5 min compared with the first 5 min, indicating that every group showed a normal habituation response (see sham operated rats treated with vehicle, OEA 2 mg/kg, OEA 10 mg/kg, PEA 2 mg/kg, PEA 10 mg/kg, respectively. AI-Veh, AI-O2, AI-O10, AI-P2, AI-P10: anoxicischemic rats treated with vehicle, OEA 2 mg/kg, OEA 10 mg/kg, PEA 2 mg/kg, PEA 10 mg/kg, respectively. Symbols and lines depict the mean ± SEM of 7-10 rats/group. ***p ≤ 0.001 Fig. 2a) . When the number of rears was analyzed, the two-way ANOVA tests revealed that the main factors Groups and Time were significant (F (9, 146) = 2.7, p = 0.005; F (1, 146) = 11.2, p = 0.001, respectively), while the interaction Group × Time was not (F (9, 146) < 1, p = n.s.). These results indicate that rats subjected to anoxia-ischemia displayed a significantly lower number of rears across the entire test compared with sham groups and that all groups showed a significantly lower number of rears during the second 5 min than during the first 5 min (see Fig. 2b ). Finally, none of the groups presented differences in anxiety-related behaviors (Entries into the center: Group, F (9, 146) = 1.6, p = n.s.; Time, F (1, 146) = 2.1, p = n.s.; Group x Time, F (9, 146) < 1, p = n.s. Time in central area: Group, F (9, 146) < 1, p = n.s.; Time, F (1, 146) = 1.1, p = n.s.; Group x Time, F (9, 146) < 1, p = n.s.) (see Fig. 2c, d ).
Palmitoylethanolamide prevents cognitive deficits that follow to neonatal anoxia-ischemia
Novel object recognition test
One-sample t tests revealed that in groups of rats subjected to anoxia-ischemia, except in the case of AI-P10 group, discrimination index (d1) and discrimination ratio (d2) did not differ from a hypothetical zero value (see Fig. 3a, b) (t values, unadjusted and adjused p values by the Benjamini-Hochberg procedure (Benjamini and Hochberg, 1995) can be found in Table S1 in the Supplementary Material file). On the other hand, sham groups and the AI-P10 group showed significantly higher d1 and d2 than the hypothetical zero value, meaning that they spent more time exploring the novel object than the familiar one (see Fig. 3a , b) (as said above, detailed statistical analyses can be found in Table S1 in the Supplementary Material file). Overall, results from this test revealed that treatment with 10 mg/kg of PEA prevented the recognition memory deficit showed by AI groups.
MWM test: cue learning
To analyze the performance of animals during the cue learning phase, the latency to reach the visible platform was used as the dependent variable. Two-way ANOVA test revealed that the main effect of Day was significant (F (1, 146) = 50.8, p < 0.001), while neither the main effect of Group nor the interaction Day × Group were (F (9, 146) < 1, p = n.s. for both cases) (see Fig. S1 ). These results mean that all groups significantly reduced their escape latency from 1 day to another, indicating the absence of visual or motor impairments and a similar level of motivation between the groups to solve the task.
MWM test: spatial learning and reference memory
To evaluate spatial memory, the dependent values latency to platform, distance to platform and swim speed were analyzed by two-way ANOVA tests. Results indicated that, in the three cases, the main factor Day was significant (Latency: F (5, 438) = 92.4, p < 0.001; Distance: F (5, 438) = 115.3, p < 0.001; Speed: F (5, 438) = 33.5, p < 0.001), while neither the main factor Group nor the interaction Group × Day were significant (Group: Latency, F (9, 438) < 1, p = n.s.; Distance: F (9, 438) = 1.1, p = n.s.; Speed, F (9, 438) < 1, p = n.s. Group x Day: Latency, F (45, 438) < 1, p = n.s.; Distance: F (45, 438) < 1, p = n.s.; Speed, F (45, 438) < 1, p = n.s.). These results show that all groups, regardless of treatment, significantly reduced their latency, distance and swim speeds at the same rate across days of learning (see Fig. 4a, c) .
When time spent in the target quadrant (the quadrant where the platform was located during the spatial learning phase) was analyzed during the probe trial, one-sample t-tests revealed that groups of rats subjected to anoxia-ischemia, except the AI-P10 group, spent a not significantly different percentage of time than expected by chance in this area (25%, dashed line). By contrast, sham groups, regardless of treatments, and the AI-P10 group spent significantly higher percentages of sham operated rats treated with vehicle, OEA 2 mg/kg, OEA 10 mg/kg, PEA 2 mg/kg, PEA 10 mg/kg, respectively. AI-Veh, AI-O2, AI-O10, AI-P2, AI-P10: anoxic-ischemic rats treated with vehicle, OEA 2 mg/kg, OEA 10 mg/kg, PEA 2 mg/kg, PEA 10 mg/kg, respectively. Bars depict the mean ± SEM of 7-10 rats/group time in the target quadrant than expected by chance (see Fig. 5a ) (Detailed statistical analyses, including t values, unadjusted and adjused p values by the Benjamini-Hochberg procedure can be found in Table S2 in the Supplementary Material file).
When it was analyzed the numbers of crossings over a circular area larger than the platform area, the two-way ANOVA test indicated that the main factor Postnatal condition was significant (F (1, 73) = 29.4, p < 0.001), while neither the main factor Treatment nor the interaction Postnatal condition × Treatment were (F (4, 73) = 1.9, p = n.s.; F (4, 73) = 1.7, p = n.s., respectively). This result indicates that rats subjected to anoxia-ischemia crossed the circular area significantly less times compared with sham groups, regardless of treatment (see Fig. 5b ). Nevertheless, as it can be seen in Fig. 5b , the AI-10 group showed a not significant trend to cross the circular area more times than the other AI groups.
Overral, these results suggest that anoxia-ischemia was associated with a spatial reference memory deficit that was prevented by the treatment with palmitoylethanolamide at a dose of 10 mg/kg.
Passive avoidance test
A two-way ANOVA test to analyze the retention index (T2/ T1) showed that neither the main factor Postnatal condition nor the main factor Treatment nor the interaction Postnatal condition × Treatment were significant (F (1, 73) < 1, p = n.s.; F (4, 73) < 1, p = n.s.; F (4, 73) < 1, p = n.s., respectively) (see Fig. S2 ). This result shows that retention index did not differ among groups, indicating that associative memory was affected neither by anoxia-ischemia nor by treatment with OEA or PEA.
Hippocampal neuroinflammation induced by neonatal anoxia-ischemia is prevented by palmitoylethanolamide administration
When the number of Iba-1 positive cells where analyzed in the CA1 hippocampal area, a two-way ANOVA test revealed that the main factors Postnatal condition (Sham and AI) and Treatment (Veh, O2, O10, P2, P10) and the interaction Postnatal condition × Treatment were all significant (F (1, 33) = 103.9, p < 0.001; F (4, 33) = 7.7, p < 0.001; F (4, 33) = 3.0, p = 0.031, respectively). Post-hoc multiple comparisons Tukey tests indicated that all groups of rats submitted to neonatal anoxia-ischemia, but the group administered with 10 mg/kg of PEA, showed a significantly higher number of Iba-1 positive cells compared with sham groups (see Fig. 6 and Fig. S3 ). Moreover, AI-P10 group showed a similar number of Iba-1 positive cells compared with sham groups (see Fig. 6 and Fig. S3 ). Finally, it was observed that treatment with OEA (2 or 10 mg/kg) or PEA (2 or 10 mg/kg) had no effect on the number of Iba-1 positive cells among sham groups (see Fig. 6 and Fig. S3) .
Similarly to what had been seen in the hippocampal CA1 area, two-way ANOVA tests revealed that the main factors Postnatal condition and Treatment and the interaction Postnatal condition x Treatment were all significant when the number of Iba-1 positive cells were analyzed in CA3 and DG areas (CA3: F (1, 33) = 156.0, p < 0.001; F (4, 33) = 13.9, p < 0.001; F (4, 33) = 3.7, p = 0.013, respectively; DG: Fig. 4 Spatial learning in the MWM. a Latency to platform. b Distance to platform. c Swim speed. Latency, distance and swim speed decreased similarly across days of training, indicating that all groups acquired the task at the same rate across days of training. Sham-Veh, Sham-O2, Sham-O10, Sham-P2, Sham-P10: sham operated rats treated with vehicle, OEA 2 mg/kg, OEA 10 mg/kg, PEA 2 mg/kg, PEA 10 mg/kg, respectively. AIVeh, AI-O2, AI-O10, AI-P2, AI-P10: anoxic-ischemic rats treated with vehicle, OEA 2 mg/kg, OEA 10 mg/kg, PEA 2 mg/kg, PEA 10 mg/kg, respectively. Symbols and lines depict the mean ± SEM of 7-10 rats/ group F (1, 33) = 94.3, p < 0.001; F (4, 33) = 11.5, p < 0.001; F (4, 33) = 16.9, p < 0.001, respectively). Post-hoc analysis also indicated that, in both hippocampal areas, the number of Iba-1 positive cells was significantly higher in the AI groups compared with sham groups, except in the case of the AI-P10 which showed a similar number of Iba-1 positive cells to sham groups (see Fig. 6 and Fig. S3 ). Finally, neither in the CA3 area nor in the DG area, sham groups differed in their number of Iba-1 positive cells (see Fig. 6 and Fig. S3 ).
Neonatal anoxia-ischemia induces an astrogliosis response that is partially reverted by palmitoylethanolamide treatment
To analyze the number of GFAP positive cells in the three areas of the hippocampus studied (CA1, CA3 and DG), twoway ANOVA tests were performed and results revealed that the main factor Postnatal condition and the interaction Postnatal condition × Treatment were both significant (CA1: F (1, 33) = 97.3, p < 0.001; F (4, 33) = 4.3, p = 0.007, respectively. CA3: F (1, 33) = 112.4, p < 0.001; F (4, 33) = 3.6, p = 0.014, respectively. DG: F (1, 33) = 69.8, p < 0.001; F (4, 33) = 3.1, p = 0.029, respectively). The main factor Treatment was not significant in any of the three hippocampal areas (CA1: F (4, 33) = 1.7, p = n.s. CA3: F (4, 33) = 1.0, p = n.s. DG: F (4, 33) = 1.6, p = n.s.).
In the CA1 area, the analyses of simple effects by post hoc Tukey tests indicated that AI groups, except the AI-P10 group, showed a significantly higher number of GFAP positive cells compared with sham groups (see Fig. 7 and Fig. S4 ). The AI-P10 showed a number of GFAP positive cells that were not significantly different in comparison with sham groups and the AI-P2 group (see Fig. 7 and Fig. S4 ). In the CA3 area, AI-Veh, AI-O2, AI-O10 and AI-P2 showed a significantly higher number of GFAP positive cells compared to sham group, while AI-P10 showed a significantly higher number of GFAP positive cells in comparison with the Sham-Veh group and significantly lower number compared with AI-Veh and AI-O10 groups (see Fig. 7 and Fig. S4 ) Finally, in the DG, AI groups, except for the AI-P10 group, showed a significantly higher number of GFAP positive cells compared with the sham groups, while the AI-P10 group did not significantly differed from the sham group and the remaining AI groups in the number of GFAP positive cells (see Fig. 7 and Fig. S4 ).
Neonatal anoxia-ischemia is associated with a reduced PPARα expression Two-way ANOVA tests revealed that the main effect of Postnatal condition was significant in all hippocampal areas when the number of PPARα was analyzed (CA1: F (1, 33) = 12.5, p = 0.01. CA3: F (1, 33) = 16.5, p < 0.001. DG: F (1, 33) = 24.5, p < 0.001), while the main effect of Treatment and the (25%, dashed line) . b Circular area crossing during the probe trial. ***p < 0.001. Bars depict the mean ± SEM of 7-10 rats/group. c Contingency plots. Sham-Veh, Sham-O2, Sham-O10, Sham-P2, Sham-P10: sham operated rats treated with vehicle, OEA 2 mg/kg, OEA 10 mg/kg, PEA 2 mg/kg, PEA 10 mg/kg, respectively. AI-Veh, AI-O2, AI-O10, AI-P2, AI-P10: anoxicischemic rats treated with vehicle, OEA 2 mg/kg, OEA 10 mg/kg, PEA 2 mg/kg, PEA 10 mg/kg, respectively interaction Postnatal condition x Treatment did not reach significance levels (Treatment: CA1: F (4, 33) = 1.2, p = n.s.; CA3: F (4, 33) = 1.3, p = n.s.; DG: F (4, 33) = 2.4, p = n.s. Postnatal condition x Treatment: CA1: F (4, 33) < 1, p = n.s.; CA3: F (4, 33) < 1, p = n.s.; DG:. F (4, 33) < 1, p = n.s.). Overall, statistical results indicate that AI groups, regardless of the treatment received, showed a significantly lower number of PPARα positive cells compared with sham groups (see Fig. 8 and Fig. S5 ).
Discussion
In the present work, we studied the potential neuroprotective effects of PEA and OEA on the hippocampus of animals exposed to neonatal AI. For this purpose, an array of behavioral tests and immunohistochemical analysis were performed. In the EPM and OF tests we were able to observe that animals exposed to AI showed a lower response to novelty, while no changes in anxiety-like behaviors were detected. Furthermore, recognition and spatial reference memory impairments were detected in NORT and MWM tests. These memory deficits were prevented by PEA treatment, while OEA administration had no detectable effects. In addition, neonatal AI was associated with an increased number of Iba-1 and GFAP positive cells in the hippocampus, a critical area for memory processing and especially vulnerable to AI (Dai et al. 2017; Zhu et al. 2018) . These neurobiological alterations could be, in part, responsible for the cognitive deficits observed, since PEA treatment was also able to prevent neuroinflammation and reduce astrogliosis. Although the neuroprotective effects of PEA have been studied in animal models of brain injury (Ahmad et al. 2012; D'Agostino et al. 2012; Esposito et al. 2012; Schomacher et al. 2008; Scuderi et al. 2018) , as far as we know this is the first time that the neuroprotective properties of PEA are reported in a neonatal model of AI.
Neonatal AI is associated with reduced novelty response but not with anxiety-related behaviors During the EPM and OF tests, we found that animals subjected to AI present a lower number of entries to the closed arms 2 mg/kg, OEA 10 mg/kg, PEA 2 mg/kg, PEA 10 mg/kg, respectively; AI-Veh, AI-O2, AI-O10, AI-P2, AI-P10: anoxic-ischemic rats treated with vehicle, OEA 2 mg/kg, OEA 10 mg/kg, PEA 2 mg/kg, PEA 10 mg/kg, respectively. SO: Stratum oriens; SP: Stratum pyramidale; SR: Stratum radiatum; SL-M: stratum lacunosum molecular; ml: molecular cell layer; gcl: granular cell layer; pcl: polymorphic cell layer. *p ≤ 0.05; **p ≤ 0.01 and ***p ≤ 0.001 vs. sham-operated groups (locomotion indicator) as well as a decrease in the total distance covered. This effect related to locomotion activity could be attributed to a decrease in the response to novelty since in the OF we only observed this change in locomotion during the first 5 min of the test, while every group presented a normal response to habituation. We, as well as others, have already observed this lower curiosity/motivation to explore novel environments in another model of hypoxia-ischemia (Galeano et al. 2011; Strackx et al. 2010) , which suggests that this effect could be related to underlying brain processes altered by oxygen deprivation rather than other mechanisms triggered by a specific animal model.
It is important to note that, unlike other authors (Ming-Yan et al. 2012; Sedláčková et al. 2014 ), we did not find changes in anxiety-related behaviors. However, this is consistent with previous results from our group in another model of global hypoxia-ischemia (Galeano et al. 2011) . We could then hypothesize that these discrepancies may be related to intrinsic differences between animal models of neonatal ischemia. Since the model employed in the present work has been recently validated, effects such as this should be noted for further studies.
PEA treatment prevents memory impairments induced by neonatal AI Animals exposed to AI showed recognition and spatial reference memory impairments, while associative memory was altered neither by AI nor by pharmacological treatments. Previous works have already found an association between alterations in both NORT and MWM tests and AI (Almli et al. 2000; Barros et al. 2009; Balduini et al. 2000; Cechetti et al. 2010; Cunha-Rodrigues et al. 2018; Domnick et al. 2015; Griva et al. 2017; Pereira et al. 2007 ). For example, Cunha-Rodrigues et al. (2018) found that pups whose mothers had been subjected to uterine artery ligation showed a recognition memory deficit concomitant with loss of hippocampal neurons. Moreover, Domnick et al. (2015) observed similar results in 2-day-old rat pups subjected to common carotid artery ligation. Regarding spatial memory, Griva et al. (2017) observed that animals subjected to left common carotid artery ligation followed by 60 min of hypoxia (8% O 2 ) showed an impaired performance in the MWM. Similarly, Cechetti et al. (2010) had already found that animals exposed to bilateral occlusion of the common carotid arteries (2VO) present deficits in spatial memory. In the present work, we were able to observe that treatment with 10 mg/kg of PEA, administered 1 h after AI, prevented recognition and reference memory deficits. So far, exogenous administration of PEA has shown to be capable of preventing memory deficits in animal models of Alzheimer's disease (D'Agostino et al. 2012; Scuderi et al. 2014 Scuderi et al. , 2018 . Regarding associative memory, similarly to what was reported by Balduini et al. (2000) , we did not observe differences between sham and AI groups, suggesting that AI has no effects on this type of memory. This results extent the previously observed neurobehavioral beneficial effects of PEA to an ischemia model, and suggest that PEA could be used as a potential treatment against memory impairments induced by different types of brain injuries.
Neuroinflammation and astrogliosis induced by AI is partially prevented by PEA treatment
In the present work, we observed a decrease in PPARα levels in animals subjected to AI, which is consistent with previous results from our group Holubiec et al. 2017) . Furthermore, the results obtained in the present study show that there is an increase in neuroinflammation (Iba-1) and astrogliosis (GFAP) in animals subjected to AI.
It has already been shown that AI leads to inflammation in different parts of the CNS (Driscoll et al. 2018) . During recent years, the role that microglia plays in disorders of the CNS has been thoroughly studied (Crews et al. 2017; Salter and Stevens 2017) . Microglia has been shown to be involved in different processes such as regulation of embryonic vasculogenesis, secretion of trophic factors, immuno-surveillance, oligodendrogenesis and neurogenesis (Mallard et al. 2018) . It has been observed that neuroinflamation due to hypoxia-ischemia plays a key and deleterious role in this event (Galinsky et al. 2018) . The production of different factors such vehicle, OEA 2 mg/kg, OEA 10 mg/kg, PEA 2 mg/kg, PEA 10 mg/kg, respectively; AI-Veh, AI-O2, AI-O10, AI-P2, AI-P10: anoxic-ischemic rats treated with vehicle, OEA 2 mg/kg, OEA 10 mg/kg, PEA 2 mg/kg, PEA 10 mg/kg, respectively. SO: Stratum oriens; SP: Stratum pyramidale; SR: Stratum radiatum; SL-M: stratum lacunosum molecular; ml: molecular cell layer; gcl: granular cell layer; pcl: polymorphic cell layer. **p ≤ 0.01 and ***p ≤ 0.001 as IL-18, Caspase-1 and TGF-β has been proven to be related to damages caused by microglia in animals exposed to AI (Chen et al. 2018; Mallard et al. 2018) . Cunha-Rodrigues et al. (2018) has described oligodendrocyte loss, astrogliosis and neuronal death due to HI. It has also been shown that animals subjected to hypoxemia present astrogliosis 6 months postinjury (Davies et al. 2018) . Furthermore, it has been previously observed that neuroinflamation and astrogliosis hold a close relation to deficits in recognition memory (Cunha-Rodrigues et al. 2018; Liaury et al. 2014 ) and spatial memory (Mirahmadi et al. 2017; Pei and Sun 2018) . Liaury et al. (2014) has found that microglial activation correlates with schizophrenia-like behaviors. Thus, we propose that the neuroinflamation and astrogliosis that we observed after AI could be resposable, in part, of the memory deficits that followed AI.
Regarding the treatment with PEA, it has already been demonstrated that this ethanolamide reduces neuroinflamation and presents a neuroprotective activity in rodents (Di Marzo and Skaper 2013; Petrosino and Di Marzo 2017; Sayd et al. 2014; Scuderi et al. 2014 ). For instance, in a rat model of Alzheimer's disease induced by the administration of intrahippocampal beta amyloid 1-42, a later treatment with PEA proved to be effective reducing neuroinflamation and exerting neuroprotective actions (Scuderi et al. 2014 ). Furthermore, PEA was shown to promote neuronal survival in the hippocampus, normalize astrocytic function and balance glutamatergic transmission, thus leading to an improvement in memory impairments (Scuderi et al. 2018) . In the present study we show that the increase in neuroinflammation and astroglyosis were partially reverted in animals treated with 10 mg/kg of PEA. Since PEA also showed a preventive effect regarding the memory deficits observed, we propose that these two phenomena may be closely related.
It is interesting to note that both PEA and OEA present antiinflammatory effects (Fidaleo et al., 2014; Franklin et al., 2003; Lowin et al. 2015; Paterniti et al. 2013; Sayd et al. 2014; Siracusa et al. 2015; Skaper et al. 2013 ) while they both have been related to different behavioral matters. For instance, it has been shown that treatment with PEA reduced or prevented (according to the administered dose) behavioral impairments and reactive gliosis produced by amyloid-β deposition (D'Agostino et al. 2012; Scuderi et al. 2014) , as well as exerting a neuroprotective effect on a model of brain ischemia (Parrella et al. 2016) . Regarding OEA, Campolongo et al. (2009) has shown that this compound enhances memory consolidation while it has also been proven that treatment with OEA in an ischemia rat model improves cognitive impairments related to hippocampus (Yang et al. 2015) . Sayd et al. (2014) showed that regarding behavior, OEA presented a beneficial effect on lipopolysaccharide-induced anhedonia, in a saccharine preference test, while PEA had no effect whatsoever over this feature. Moreover, in another model of ischemia, OEA proved to be able to prevent its effects, but only in a dose dependent manner, being the 40 mg/kg dose the most effective (Zhou et al. 2012) .
In the present work, we have observed that PEA, but not OEA, exerts an anti-inflammatory effect on the damaged hippocampus. Although these two ethanolamides are quite similar regarding their biosynthetic pathways and structures, PEA has long been known for its anti-inflammatory and anti-nociceptive properties, while OEA is particularly known for its regulation of feeding (Ho et al. 2008) . Studies regarding inflammation in burning mouth syndrome have recently revealed that this disease is particularly associated with an increase in PEA but not in OEA levels (Barry et al. 2018) . Studies carried out during the last two decades have found that PEA acts as what is called an Bentourage compound^of AEA, meaning that the presence of PEA increases AEAs anti-inflammatory actions, probably inhibiting AEA degradation. Despite being found that OEA is capable of decreasing AEA degradation there is far less evidence of this compound as an Bentourage compound^ (Ho et al. 2008) . Moreover, PEA has been found to increase CB2 mRNA levels in microglia through its interaction with PPARα, thus enhancing AEAs antiinflammatory actions in the nervous system (Guida et al. 2017) . What is most interesting is that despite its neuroprotective properties in stroke models, OEA presents a rapid degradation which can limit its therapeutic effects (Kossatz et al. 2018) . Zhou et al. (2012) proved the therapeutic effects of OEA, but only less than 24 h after the insult and treatment, and with a dose considerably higher than the ones used in the present work. These and our results lead us to believe that while OEA indeed has anti-inflammatory and neuroprotective features in the hippocampus, its fast degradation and the need to use high doses did not allow us to observe its potentially beneficial effects in the present study.
Conclusions
In the present work, we show that AI is associated with recognition and spatial memory impairments in a new model of neonatal AI. We have also found that these memory deficits may be related to neuroinflammation and astrogliosis in the hippocampus, since PEA treament partially reversed this alterations and it was able to prevent memory impairments. Although PEA has shown to posses neuroprotective effects in different types of brain injuries, as far as we know this is the first time that these neuroprotetive effects of PEA are observed in a neonatal AI model. Overall, these results indicate that PEA could be a good candidate to focus on in further studies related to AI, a traumantic and not so uncommon event for which effective treatments are lacking.
